Erythroferrone inhibits the induction of hepcidin by BMP6
Decreased hepcidin mobilizes iron, which facilitates erythropoiesis, but excess iron is pathogenic in beta-thalassemia. Erythropoietin (EPO) enhances erythroferrone (ERFE) synthesis by erythroblasts, and ERFE suppresses hepatic hepcidin production, through an unknown mechanism. The BMP/SMAD pathway...
Main Authors: | Arezes, J, Foy, N, McHugh, K, Sawant, A, Quinkert, D, Terraube, V, Brinth, A, Tam, M, Lavallie, E, Taylor, S, Armitage, A, Pasricha, S, Cunningham, O, Lambert, M, Draper, S, Jasuja, R, Drakesmith, H |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society of Hematology
2018
|
Similar Items
-
Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia
by: Arezes, J, et al.
Published: (2020) -
Erythroferrone: An Erythroid Regulator of Hepcidin and Iron Metabolism
by: Richard Coffey, et al.
Published: (2018-04-01) -
Regulation of hepcidin by erythropoiesis: The story so far.
by: Pasricha, S, et al.
Published: (2016) -
Erythroferrone and hepcidin levels in children with iron deficiency anemia
by: Ramazan Dulkadir, et al.
Published: (2024-04-01) -
A Comprehensive Analysis of the Erythropoietin-erythroferrone-hepcidin Pathway in Hereditary Hemolytic Anemias
by: Annelies J. van Vuren, et al.
Published: (2021-09-01)